Revenue (Tables)

6 Months Ended

Jun. 30, 2023

Revenue from Contract with Customer [Abstract]

The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and six-month periods ended June 30, 2023 and July 1, 2022 ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue.


	Biotechnology		Life Sciences		Diagnostics		Environmental & Applied Solutions		Total
For the Three-Month Period Ended June 30, 2023:
Geographical region:
North America(a)	$	611	$	757	$	982	$	577	$	2,927
Western Europe	684		375		365		284		1,708
Other developed markets(b)	72		124		100		31		327
High-growth markets(c)	518		540		784		353		2,195
Total	$	1,885	$	1,796	$	2,231	$	1,245	$	7,157

Revenue type:
Recurring	$	1,534	$	1,104	$	1,958	$	742	$	5,338
Nonrecurring	351		692		273		503		1,819
Total	$	1,885	$	1,796	$	2,231	$	1,245	$	7,157

For the Three-Month Period Ended July 1, 2022:
Geographical region:
North America(a)	$	798	$	778	$	1,235	$	571	$	3,382
Western Europe	632		340		453		266		1,691
Other developed markets(b)	88		111		115		32		346
High-growth markets(c)	748		472		758		354		2,332
Total	$	2,266	$	1,701	$	2,561	$	1,223	$	7,751

Revenue type:
Recurring	$	1,804	$	1,068	$	2,301	$	719	$	5,892
Nonrecurring	462		633		260		504		1,859
Total	$	2,266	$	1,701	$	2,561	$	1,223	$	7,751


	Biotechnology		Life Sciences		Diagnostics		Environmental & Applied Solutions		Total
For the Six-Month Period Ended June 30, 2023:
Geographical region:
North America(a)	$	1,229	$	1,465	$	2,106	$	1,149	$	5,949
Western Europe	1,331		739		785		561		3,416
Other developed markets(b)	151		252		217		60		680
High-growth markets(c)	1,038		1,049		1,499		693		4,279
Total	$	3,749	$	3,505	$	4,607	$	2,463	$	14,324

Revenue type:
Recurring	$	3,045	$	2,143	$	4,070	$	1,466	$	10,724
Nonrecurring	704		1,362		537		997		3,600
Total	$	3,749	$	3,505	$	4,607	$	2,463	$	14,324

For the Six-Month Period Ended July 1, 2022:
Geographical region:
North America(a)	$	1,580	$	1,516	$	2,541	$	1,099	$	6,736
Western Europe	1,339		668		977		535		3,519
Other developed markets(b)	173		248		239		64		724
High-growth markets(c)	1,390		935		1,448		687		4,460
Total	$	4,482	$	3,367	$	5,205	$	2,385	$	15,439

Revenue type:
Recurring	$	3,605	$	2,105	$	4,671	$	1,409	$	11,790
Nonrecurring	877		1,262		534		976		3,649
Total	$	4,482	$	3,367	$	5,205	$	2,385	$	15,439

(a) The Company defines North America as the United States and Canada.

(b) The Company defines other developed markets as Japan, Australia and New Zealand.

(c) The Company defines high-growth markets as developing markets of the world experiencing extended periods of accelerated growth in gross domestic product and infrastructure which include Eastern Europe, the Middle East, Africa, Latin America (including Mexico) and Asia (with the exception of Japan, Australia and New Zealand). The Company defines developed markets as all markets of the world that are not high-growth markets.